B-LYMPHOCYTE COUNT INCREASED

B-LYMPHOCYTE COUNT INCREASED was reported 186 times

These drug classes are most commonly taken by patients reporting B-LYMPHOCYTE COUNT INCREASED:

# Drug Count
0 CD20-directed Cytolytic Antibody [EPC] 102
1 Corticosteroid [EPC] 57
2 Nonsteroidal Anti-inflammatory Drug [EPC] 22
3 CD52-directed Cytolytic Antibody [EPC] 15
4 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 12
5 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 12
6 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 12
7 Potassium Channel Blocker [EPC] 12
8 Loop Diuretic [EPC] 9
9 beta3-Adrenergic Agonist [EPC] 9
10 Integrin Receptor Antagonist [EPC] 8
11 Proton Pump Inhibitor [EPC] 8
12 Alkylating Drug [EPC] 7
13 Expectorant [EPC] 7
14 Calcineurin Inhibitor Immunosuppressant [EPC] 6
15 HMG-CoA Reductase Inhibitor [EPC] 6
16 Histamine-1 Receptor Antagonist [EPC] 6
17 Osmotic Laxative [EPC] 6
18 Provitamin D2 Compound [EPC] 6
19 Purine Antimetabolite [EPC] 6
20 Calcium [EPC] 5
21 Estrogen [EPC] 5
22 Folate Analog Metabolic Inhibitor [EPC] 5
23 gamma-Aminobutyric Acid-ergic Agonist [EPC] 5
24 Benzodiazepine [EPC] 4
25 Calcium Channel Blocker [EPC] 4
26 Dihydropyridine Calcium Channel Blocker [EPC] 4
27 Histamine-2 Receptor Antagonist [EPC] 4
28 Human Immunoglobulin G [EPC] 4
29 Platelet Aggregation Inhibitor [EPC] 4
30 Progesterone [EPC] 4
31 Vitamin C [EPC] 4
32 Angiotensin 2 Receptor Blocker [EPC] 3
33 Angiotensin Converting Enzyme Inhibitor [EPC] 3
34 Anti-epileptic Agent [EPC] 3
35 BCL-2 Inhibitor [EPC] 3
36 Central alpha-2 Adrenergic Agonist [EPC] 3
37 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 3
38 Erythropoiesis-stimulating Agent [EPC] 3
39 General Anesthetic [EPC] 3
40 Insulin Analog [EPC] 3
41 Interferon beta [EPC] 3
42 Mood Stabilizer [EPC] 3
43 Opioid Agonist [EPC] 3
44 Serotonin Reuptake Inhibitor [EPC] 3
45 Sulfonamide Antimicrobial [EPC] 3
46 Tumor Necrosis Factor Blocker [EPC] 3
47 Vitamin B12 [EPC] 3
48 Vitamin D [EPC] 3
49 Xanthine Oxidase Inhibitor [EPC] 3
50 beta-Adrenergic Blocker [EPC] 3
51 Aldosterone Antagonist [EPC] 2
52 CD19-directed Cytolytic Antibody [EPC] 2
53 CD38-directed Cytolytic Antibody [EPC] 2
54 Catecholamine [EPC] 2
55 Guanylate Cyclase-C Agonist [EPC] 2
56 Kinase Inhibitor [EPC] 2
57 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2
58 Phosphodiesterase 5 Inhibitor [EPC] 2
59 Proteasome Inhibitor [EPC] 2
60 Thiazide Diuretic [EPC] 2
61 alpha-Adrenergic Agonist [EPC] 2
62 beta-Adrenergic Agonist [EPC] 2
63 Aromatic Amino Acid [EPC] 1
64 Atypical Antipsychotic [EPC] 1
65 Azole Antifungal [EPC] 1
66 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1
67 CD19-directed Chimeric Antigen Receptor [EPC] 1
68 Dietary Cholesterol Absorption Inhibitor [EPC] 1
69 Endoglycosidase [EPC] 1
70 Factor Xa Inhibitor [EPC] 1
71 GLP-1 Receptor Agonist [EPC] 1
72 Genetically-modified Autologous T Cells [EPC] 1
73 Glinide [EPC] 1
74 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
75 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
76 Interleukin-17A Antagonist [EPC] 1
77 Interleukin-6 Receptor Antagonist [EPC] 1
78 Leukocyte Growth Factor [EPC] 1
79 Microtubule Inhibitor [EPC] 1
80 Nonergot Dopamine Agonist [EPC] 1
81 Nucleoside Analog Antiviral [EPC] 1
82 PCSK9 Inhibitor [EPC] 1
83 Parathyroid Hormone Analog [EPC] 1
84 Platinum-based Drug [EPC] 1
85 Polyene Antifungal [EPC] 1
86 Potassium Binder [EPC] 1
87 Progestin [EPC] 1
88 Progestin-containing Intrauterine System [EPC] 1
89 Prostaglandin Analog [EPC] 1
90 RNA Synthetase Inhibitor Antibacterial [EPC] 1
91 Sulfone [EPC] 1
92 Sympathomimetic-like Agent [EPC] 1
93 Thrombopoietin Receptor Agonist [EPC] 1
94 Vitamin D3 Analog [EPC] 1
95 alpha-Adrenergic Blocker [EPC] 1